FDA Inspection 1116270 — New York Blood Center, Inc.
The FDA completed an inspection of New York Blood Center, Inc. on Jan 24, 2020 in Paramus, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 24, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Paramus, NJ (United States)